Your browser doesn't support javascript.
loading
Cryo-EM structure of human HCN3 channel and its regulation by cAMP.
Yu, Bo; Lu, Qiuyuan; Li, Jian; Cheng, Xinyu; Hu, Han; Li, Yuanshuo; Che, Tong; Hua, Yaoguang; Jiang, Haihai; Zhang, Yuting; Xian, Cuiling; Yang, Tingting; Fu, Ying; Chen, Yixiang; Nan, Weiwei; McCormick, Peter J; Xiong, Bing; Duan, Jingjing; Zeng, Bo; Li, Yanyan; Fu, Yang; Zhang, Jin.
Afiliação
  • Yu B; The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China; The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • Lu Q; School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.
  • Li J; College of Pharmacy, Gannan Medical University, Ganzhou, China.
  • Cheng X; The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China; The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • Hu H; Shenzhen Crystalo Biopharmaceutical Co, Ltd, Shenzhen, Guangdong, China.
  • Li Y; Shenzhen Crystalo Biopharmaceutical Co, Ltd, Shenzhen, Guangdong, China.
  • Che T; The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China; The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • Hua Y; The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China; The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • Jiang H; The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China; The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • Zhang Y; Shenzhen Crystalo Biopharmaceutical Co, Ltd, Shenzhen, Guangdong, China.
  • Xian C; Shenzhen Crystalo Biopharmaceutical Co, Ltd, Shenzhen, Guangdong, China.
  • Yang T; The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China; The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • Fu Y; The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China; The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • Chen Y; The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China; The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • Nan W; The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China; The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • McCormick PJ; William Harvey Research Institute, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Xiong B; Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Duan J; Human Aging Research Institute (HARI), School of Life Sciences, Nanchang University, Nanchang, Jiangxi, China.
  • Zeng B; Key Laboratory of Medical Electrophysiology, Ministry of Education & Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University, Luzhou, Sichuan, China.
  • Li Y; Department of Chemical Biology, School of Life Southern University of Science and Technology, Southern University of Science and Technology, Shenzhen, Guangdong, China; Institute for Biological Electron Microscopy, Southern University of Science and Technology, Shenzhen, Guangdong, China. Electronic
  • Fu Y; School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China. Electronic address: fuy@sustech.edu.cn.
  • Zhang J; The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China; The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China. Electronic addre
J Biol Chem ; 300(6): 107288, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38636662
ABSTRACT
HCN channels are important for regulating heart rhythm and nerve activity and have been studied as potential drug targets for treating depression, arrhythmia, nerve pain, and epilepsy. Despite possessing unique pharmacological properties, HCN channels share common characteristics in that they are activated by hyperpolarization and modulated by cAMP and other membrane lipids. However, the mechanisms of how these ligands bind and modulate HCN channels are unclear. In this study, we solved structures of full-length human HCN3 using cryo-EM and captured two different states, including a state without any ligand bound and a state with cAMP bound. Our structures reveal the novel binding sites for cholesteryl hemisuccinate in apo state and show how cholesteryl hemisuccinate and cAMP binding cause conformational changes in different states. These findings explain how these small modulators are sensed in mammals at the molecular level. The results of our study could help to design more potent and specific compounds to influence HCN channel activity and offer new therapeutic possibilities for diseases that lack effective treatment.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: AMP Cíclico / Microscopia Crioeletrônica / Canais Disparados por Nucleotídeos Cíclicos Ativados por Hiperpolarização Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: AMP Cíclico / Microscopia Crioeletrônica / Canais Disparados por Nucleotídeos Cíclicos Ativados por Hiperpolarização Idioma: En Ano de publicação: 2024 Tipo de documento: Article